These are GLP-1 receptor agonists originally developed to manage Type 2 diabetes but now widely used for weight loss
Published human trials of DSIP are decades old, used very small samples, and produced mixed results
Some people notice a slight decrease in appetite
D., Chen, T.-C., Davy, O., Fink, S., Fryar, C
Low Blood Sugar and Retatrutide: Risks, Symptoms, and Safe Management Low blood sugar (hypoglycaemia) is an important safety consideration for anyone taking retatrutide, an investigational triple receptor agonist currently being evaluated in clinical trials
It has a very full database of foods and when I cant find something I can easily take a picture of my meal, or the nutrition label and it uploads it, saves for easy access next time when I eat the same meals